Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd.’s Net Profit Rose 18% in First Half of 2023

Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd. (漳州片仔癀药业股份有限公司) (600436.SH) reported a net profit of 1.6 billion yuan in the first half of 2023, up 18% year-on-year.

Meanwhile, the company posted 5 billion yuan in revenue, up 14.1% year-on-year.

At the end of the reporting period, it had 15.9 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 20.4%.